Tokyo, Japan

Masaru Kanagawa

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Nihon Medi-Physics Company, Limited. Active years: 2003-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaru Kanagawa. Retrieved from https://idiyas.com/inventor/masaru-kanagawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 25(Granted Patents)


Location History:

  • Sodegaura, JP (2003)
  • Tokyo, JP (2020)

Company Filing History:


Years Active: 2003-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Masaru Kanagawa

Introduction

Masaru Kanagawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of diagnostic imaging, particularly in the context of cancer research. With a total of 2 patents, his work has the potential to impact early detection and treatment strategies for cancer patients.

Latest Patents

Kanagawa's latest patents include a diagnostic imaging agent for early bone metastasis from cancer. This innovative agent contains trans-1-amino-[F]fluorocyclobutanecarboxylic acid or a pharmaceutically acceptable salt thereof as an active ingredient. Additionally, he has developed a bisphosphonic acid derivative and a compound thereof labeled with a radioactive nuclide, further enhancing the capabilities of diagnostic imaging in oncology.

Career Highlights

Masaru Kanagawa is currently associated with Nihon Medi-Physics Company, Limited, where he continues to advance his research and development efforts. His work is crucial in the ongoing battle against cancer, providing new tools for early diagnosis and treatment.

Collaborations

Some of his notable coworkers include Osamu Ito and Nobuhiko Kanazashi, who contribute to the collaborative efforts in their research projects.

Conclusion

Masaru Kanagawa's innovative work in diagnostic imaging represents a significant advancement in cancer research. His contributions are paving the way for improved early detection methods, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…